Products

Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Canine Programmed cell death 1 (PDCD1) ELISA Kit-Sandwich

Name: Canine Programmed cell death 1 (PDCD1) ELISA Kit-Sandwich
SKU: EK10F833
Rating: 5 (1 reviews)

Cat. No.EK10F833

Product TypeAnimal Immunoassay Kits

Size

Inquiry Now Add to Inquiry List

Product Overview

BioVenic Canine PDCD1 ELISA Kit-Sandwich is designed for the quantitative determination of Canine PDCD1 in serum, plasma, tissue homogenate, cell culture supernatant, cell lysate, and other biological fluids using a Sandwich ELISA method. For research use only.

Specifications

Assay Type ELISA-Sandwich

Specificity The assay kit is specific for Canine PDCD1.

Target Species Canine

Species Reactivity Canine

Detection Range 0.2-10 ng/mL

Sensitivity 0.03 ng/mL

Reproducibility Intra-Assay: CV < 10%; Inter-Assay: CV < 10%

Assay Time Around 180 min

Sample Requirement Serum, plasma, tissue homogenate, cell culture supernatant, cell lysate, and other biological fluids.

Target Information

Programmed cell death 1 is encoded by the PDCD1 gene in dogs. Interruption of the programmed death 1 (PD-1) / programmed death ligand 1 (PD-L1) pathway is an established and effective therapeutic strategy in human oncology and holds promise for veterinary oncology.

Target/Biomarker Canine PDCD1

Target Synonym programmed cell death 1; PD-1; programmed cell death protein 1; programmed death 1

Gene ID 486213

UniProt ID A0A090BAM7

Shipping and Storage

This product is shipped with gel ice packs. It is recommended to store at 2-8 °C (Up to 6 months).

Documents

Datasheet

COA

To request a Certificate of Analysis, please enter the Lot No. in the search box. Note: Certificate of Analysis not available for kits.

The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.

References

Choi, J. W. et al. Development of canine PD-1/PD-L1 specific monoclonal antibodies and amplification of canine T cell function. PloS one. 2020, 15: e0235518.